Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes

Journal of Clinical Oncology

Volumn 30, Issue 2, 2012, Pages 179-183

  Goldin, Lynn R ^a   Kristinsson, Sigurdur Y ^b   Liang, Xueying Sharon ^a   Derolf, Åsa R ^b   Landgren, Ola ^a   Björkholm, Magnus ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; NONHODGKIN LYMPHOMA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RELATIVE; SOLID TUMOR; THROMBOCYTHEMIA;

AGED; FAMILY HEALTH; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PEDIGREE; RISK FACTORS; SWEDEN;

EID: 84855596373     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.1203     Document Type: Article

References (28)

1. Deschler B, Lübbert M: Acute myeloid leukemia: Epidemiology and etiology. Cancer 107:2099- 2107, 2006
2. Bowen DT: Etiology of acute myeloid leukemia in the elderly. Semin Hematol 43:82-88, 2006
3. Linet M, Devesa SS, Morgan GJ: The leukemias, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 3). New York, NY, Oxford University Press, 2006, pp 841-871
4. Ma X, Park Y, Mayne ST, et al: Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort. Am J Epidemiol 171:312-322, 2010
5. Smith MT, Zhang L, McHale CM, et al: Benzene, the exposome and future investigations of leukemia etiology. Chem Biol Interact 192:155-159, 2011
6. Anderson LA, Pfeiffer RM, Landgren O, et al: Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100:822-828, 2009
7. Kristinsson SY, Björkholm M, Hultcrantz M, et al: Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29: 2897-2903, 2011
8. Owen C, Barnett M, Fitzgibbon J: Familial myelodysplasia and acute myeloid leukaemia: A review. Br J Haematol 140:123-132, 2008 (Pubitemid 350265048)
9. Owen CJ, Toze CL, Koochin A, et al: Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood 112:4639-4645, 2008
10. Preudhomme C, Renneville A, Bourdon V, et al: High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder. Blood 113:5583-5587, 2009
11. Ripperger T, Steinemann D, Göhring G, et al: A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: Can these families serve as a multistep model for leukemic transformation? Leukemia 23:1364-1366, 2009
12. Pabst T, Eyholzer M, Haefliger S, et al: Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. J Clin Oncol 26:5088-5093, 2008
13. Gunz FW, Gunz JP, Veale AM, et al: Familial leukaemia: A study of 909 families. Scand J Haematol 15:117-131, 1975
14. Cannon-Albright LA, Thomas A, Goldgar DE, et al: Familiality of cancer in Utah. Cancer Res 54:2378-2385, 1994 (Pubitemid 24138728)
15. Kerber RA, O'Brien E: A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103:1906-1915, 2005 (Pubitemid 40563264)
16. Roddam PL, Rollinson S, Kane E, et al: Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. Pharmacogenetics 10:605-615, 2000
17. Das P, Shaik AP, Bammidi VK: Meta-analysis study of glutathione-S- transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia. Leuk Lymphoma 50:1345-1351, 2009
18. Calado RT, Regal JA, Hills M, et al: Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci U S A 106:1187-1192, 2009
19. Kristinsson SY, Landgren O, Samuelsson J, et al: Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95:1216-1220, 2010
20. Derolf AR, Kristinsson SY, Andersson TM, et al: Improved patient survival for acute myeloid leukemia: A population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 113:3666-3672, 2009
21. Skarle A: Flergenerationsregistret. Stockholm, Sweden, Statistics Sweden, Population Statistics, 2001
22. Pfeiffer RM, Goldin LR, Chatterjee N, et al: Methods for testing familial aggregation of diseases in population-based samples: Application to Hodgkin lymphoma in Swedish registry data. Ann Hum Genet 68:498-508, 2004 (Pubitemid 39409546)
23. Goldin LR, Björkholm M, Kristinsson SY, et al: Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 94:647-653, 2009
24. Goldin LR, Björkholm M, Kristinsson SY, et al: Highly increased familial risks for specific lymphoma subtypes. Br J Haematol 146:91-94, 2009
25. Goldin LR, Pfeiffer RM, Gridley G, et al: Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902-1908, 2004 (Pubitemid 38529568)
26. Kristinsson SY, Björkholm M, Goldin LR, et al: Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer 125:2147-2150, 2009
27. Landgren O, Goldin LR, Kristinsson SY, et al: Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood 112: 2199-2204, 2008
28. Bacher U, Schnittger S, Haferlach T: Molecular genetics in acute myeloid leukemia. Curr Opin Oncol 22:646-655, 2010